Rapid and sensitive on-site measurement of antibodies against the Covid-19 virus
The new research was led by Yoshihiro Ito at RIKEN CEMS, who developed a technology several years ago…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Sep 21
The new research was led by Yoshihiro Ito at RIKEN CEMS, who developed a technology several years ago…
07 Sep 21
In a cohort of 1,696 patients, iBiopsy CADx demonstrated a sensitivity of 95.2% and specificity of 95.7% for…
07 Sep 21
Culture and Sensitivity Testing (C&ST) failed to detect the minor pathogen population in individual mixed samples, with final…
07 Sep 21
The new research was led by Yoshihiro Ito at RIKEN CEMS, who developed a technology several years ago…
02 Sep 21
Earlier collaboration, starting with a multiyear, global agreement, may speed development and introduction of targeted precision medicine therapies…
01 Sep 21
The funds will be used by the company to speed up the global deployment of rapid genetic testing…
01 Sep 21
The blood test would also facilitate early detection and monitoring of patients with other cancer-predisposing genetic disorders
01 Sep 21
The Baseline platform enables better and faster clinical trial execution, improved data aggregation and analysis, flexible study options…
31 Aug 21
The INDICAID Covid-19 Rapid Antigen Test is a lateral flow immunoassay designed for qualitative detection of SARS-CoV-2 antigens
27 Aug 21
New blood test is designed to reduce the number of false positive results and provide improved diagnostic guidance…